Subscribe: - Health
Added By: Feedage Forager Feedage Grade B rated
Language: English
allergy drug  approval  astrazeneca  cancer drug  chief  clinical trial  drug  health  investors  new  peanut allergy  potential  reckitt 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: - Health



Last Build Date: Thu, 22 Feb 2018 12:34:17 GMT

Copyright: © Copyright The Financial Times Ltd 2018. "FT" and "Financial Times" are trademarks of the Financial Times. See for the terms and conditions of reuse.

High Court rules UK air pollution plan is ‘unlawful’

Wed, 21 Feb 2018 15:58:38 GMT

Government says it will take a firmer line in 45 local authorities where pollution levels breached

Russia’s middle class opens door to private healthcare providers

Wed, 21 Feb 2018 13:15:02 GMT

Strains on public system and cost of treatment abroad drive demand for western medicine

A new peanut allergy drug could force a change of behaviour

Wed, 21 Feb 2018 05:00:42 GMT

Aimmune’s potential cure may be onerous, but that is not necessarily a bad thing

UK government threatens to strip Oxfam of public contracts

Tue, 20 Feb 2018 23:34:49 GMT

Charity chief apologises for failings as donations slow

Peanut allergy drug nears approval after clinical trial success

Tue, 20 Feb 2018 18:23:31 GMT

Treatment has potential for $1bn annual sales but investors fret over dropout rates

Aimmune’s peanut allergy drug succeeds in late stage clinical trial

Tue, 20 Feb 2018 12:49:28 GMT

Treatment on track to be first approved for potentially fatal condition

Hikma appoints new CEO at ‘pivotal’ time

Tue, 20 Feb 2018 07:36:11 GMT

Leadership change follows series of snags

UK charities warn on high debt levels among mental health patients

Tue, 20 Feb 2018 00:01:56 GMT

‘Breathing space’ needed to allow heavily indebted to manage their debts

Reckitt must work through growing pains to win healthy support

Mon, 19 Feb 2018 20:52:09 GMT

Investors will need persuading before coughing up to aid Rakesh Kapoor’s plans

AstraZeneca: hoist the sales

Mon, 19 Feb 2018 17:29:06 GMT

Pharmaceutical group opens up multibillion-dollar market after cancer drug approved

Reckitt Benckiser shares hit amid concern over margin outlook

Mon, 19 Feb 2018 15:52:14 GMT

Investors mark down consumer goods group despite promises it will return to ‘outperformance’

AstraZeneca hails ‘milestone’ US approval for lung cancer drug

Mon, 19 Feb 2018 12:50:24 GMT

FDA move boosts Imfinzi treatment’s blockbuster potential

AstraZeneca wins FDA approval for key cancer drug

Mon, 19 Feb 2018 07:53:04 GMT

Chief executive Pascal Soriot has bet on new drugs to meet ambitious growth targets

Chinese city touted as model for cutting healthcare costs

Mon, 19 Feb 2018 01:32:32 GMT

Cheaper drugs cut burden on Sanming budget, but locals grumble over quality of care

Breakthrough over growing human organs in animals

Sun, 18 Feb 2018 15:56:15 GMT

Scientists create hybrid embryos with stem cells from both species

Is the NHS still suffering ‘permanent winter’?

Fri, 16 Feb 2018 19:18:10 GMT

FT data show struggling health service with glimmers of hope

FT Health: Lessons from the Oxfam scandal

Fri, 16 Feb 2018 12:42:37 GMT

UK chief for Pasteur Institute, cognitive prosthetics, fighting diabetes via hip hop

Good bacteria can help brain function better  

Thu, 15 Feb 2018 23:38:24 GMT

Scientists investigate link between gut, mood and memory

Getting medicines to the people who need them

Thu, 15 Feb 2018 18:06:37 GMT

Critics say regulation is needed but a voluntary approach may be more effective

Pharma groups deliver mixed performance

Thu, 15 Feb 2018 16:52:55 GMT

Irish drugmaker Horizon Pharma raises painkiller price to $3,000 in US

Thu, 15 Feb 2018 07:12:46 GMT

Cost of two-in-one bottle surges even though drugs can be bought separately for $36